[1]
“Β-CARYOPHYLLENE AS A PARTNER FOR DOXORUBICIN: EVIDENCE FOR CHEMOSENSITISATION, TISSUE PROTECTION AND LIPID-BASED CO-DELIVERY”, FMHR, vol. 4, no. 3, pp. 4636–4645, Mar. 2026, Accessed: Nov. 09, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/3855